Episode Details

Back to Episodes
Zepbound - Tirzepatide for obesity approval

Zepbound - Tirzepatide for obesity approval

Episode 73 Published 2 years, 2 months ago
Description

Drs. Karl and Spencer discuss how tirzepatide is now approved for obesity.

Learn:

  1. When will it be available
  2. How much will is cost
  3. Any differences compared to Mounjaro
  4. Surmount 3 trial



Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us